630-580-1088 sales@ambeed.com
Structure Search

List Search MOL Search Structure Search

0
Chemistry
Boronic acids/esters >>1,3,2-DioxaborinaneAliphatic BoronsAromatic BoronsBCATBoric AcidsMIDA BoronatesOther BoronatesOther BoronsOxaborolesCatalysis Chemistry >>Achiral Crown LigandsC-H ActivationCarbon-Donor LigandsChiral Carbon LigandsChiral Crown LigandsChiral Olefin LigandsCross-CouplingCross-Coupling Using Transition Metal CatalystsDACH or Trost LigandsChemical Biology >>Conjugation Chemistry
GlycoscienceLinkers and CrosslinkersNucleic Acid ChemistryPEGylationPeptide ChemistryPhotolabile Protecting GroupHeterocyclic Building Blocks >>AcridinesAliphatic HeterocyclesAromatic HeterocyclesAzetidinesBenzimidazolesBenzisoxazolesBenzodioxansBenzofuransBenzothiazolesInorganic reagents >>Inorganic ReagentOrganic Building Blocks >>Acid AnhydridesAcyl ChloridesAlcohols
AldehydesAliphatic Chain HydrocarbonsAliphatic Cyclic HydrocarbonsAlkenesAlkylsAlkynesOrganometallic Reagents >>Grignard ReagentsOrganoarsenicOrganobismuthOrganoboronOrganogermaniumOrganolithiumOrganomercuryOrganosiliconOrganotinSpecialty Synthesis >>Enzyme-Mediated SynthesisFluorous SynthesisIonic LiquidsSolid Supported SynthesisStains and Dyes >>
Acid DyesAzoic DyesBasic DyesDirect DyesDisperse DyesDye IntermediatesMordant DyesOil DyesOther Stains and DyesSynthetic Reagents >>Acids and BasesC-C Bond FormationC-X Bond Formation (Halogen)C-X Bond Formation (Non-Halogen)Chelation and Complexation CompoundsCondensation AgentsCouplingDehydrating ReagentsFluorination Reagent
Pharmaceutical Intermediates
Analgesics >>BenzhydrocodoneBicifadineCapsaicinCelecoxibDebio-0827DexamethasoneElagolix SodiumEsketamine HydrochlorideIbuprofen SodiumAnesthetics >>CiprofolEsketamine HydrochlorideFospropofol Fospropofol DisodiumLevobupivacaine RemimazolamRemimazolam BesilateRemimazolam BesylateRopivacaineAnti-Addiction Agents >>Kakonein
Lofexidine HydrochlorideVarenicline Anti-inflammatory Agents >>ApremilastAsunaprevirATB-346 RelatedBalsalazide BaricitinibBencycloquidium BromideBudesonideCefiderocol Sulfate TosylateCeftaroline Fosamil AcetateAntibacterials >>AFN-1252 RelatedAlatrofloxacin Bedaquiline FumarateBesifloxacin BrilacidinCaspofungin AcetateCefiderocol Sulfate TosylateCefilavancinCeftaroline Fosamil
Anticonvulsants >>BrivaracetamCannabidiolEscitalopram OxalateEslicarbazepine Acetate RelatedFosphenytoinGabapentin EnacarbilJNJ-10234094LacosamideLevetiracetam RelatedAntidementia Agents >>Azeliragon RelatedDavunetideDonepezil HydrochlorideDonepezil RelatedEnsaculinFlorbetaben Flortaucipir F 18Flutemetamol IdalopirdineAntidepressants >>4-Chlorokynurenine
AgomelatineAgomelatine RelatedAllopregnanolone RelatedAmibegronAmitifadineAripiprazole RelatedBasimglurantBefloxatoneAntiemetics >>AprepitantAprepitant RelatedDolasetron RelatedDolasetron Mesylate HydrateFosaprepitant DimeglumineFosaprepitant RelatedOlanzapinePalonosetron RelatedPalonosetron HydrochlorideAntifungals >>Anidulafungin RelatedCabotegravirMore >>
Inhibitors/Agonists
ADC >>ADC AntibodyADC LinkerADC Linker with PayloadADC ToxinAntibody-Drug Conjugates (ADCs)Drug-Linker Conjugates for ADCAngiogenesis >>ALKBcr-AblBTKEGFRFAKFGFRFLT3HER2HIFAnti-infection >>3CLproAntibacterialAntibioticAntifungal
AntiparasiticAntiprotozoalAntiviralArenavirusBVDVApoptosis >>Apoptosis InducerBcl-2Bcl-6BRKc-Mycc-RETC/EBPCARDCaspaseAutophagy >>Atg4ATG4BATTECsAUTACsAutophagyBeclin1
FKBPLC3LRRK2Biochemical Reagent >>Cell Cycle >>AntifolateAPCAurora KinaseBUBCasein KinaseCdc25CDKChkCRISPR/Cas9Cytoskeleton >>ActinArp2/3 ComplexCYTHCytoplasmic DyneinDynaminFAKMore >>
Material Science
Aggregation-Induced Emission >>Other AIE BlocksTetraphenylethylene SeriesCOFs Linkers >>Aldehyde COFs LinkersAlkynyl COFs LinkersAmine COFs LinkersBoric COFs LinkersCyano COFs LinkersMultifunctional COFs linkersOther COFs linkersTriptycene SeriesElectronic Materials >>Battery MaterialsDye-Sensitized Solar Cell (DSSC) MaterialsElectronic MaterialLiquid Crystal (LC) MaterialsMolecular ConductorsOrganic Light-Emitting Diode (OLED) MaterialsOrganic Solar Cell (OPV) MaterialsOrganic Transistor (OFET) MaterialsPerovskite Solar Cell (PSC) MaterialsMagnetic Materials >>Magnetic Ionic LiquidsMagnetic MaterialMagnetic Metal Complexes
Organic Radicals Material Chemical Compounds >>Ligands for Functional Metal ComplexesLiquid Crystal (LC) Building BlocksPhthalocyanine Building BlocksPolymer and Macromolecule Semiconductor Building BlocksSmall Molecule Semiconductor Building BlocksSolubility Enhancing Reagents Supramolecular Host Materials MOF Ligands >>Carboxylic Acid MOF LigandsCarboxylic Acid Nitrogen-Containing Mixed MOF LigandsNitrogen-Containing MOF LigandsOther MOF LigandsNanomaterials >>Carbon NanomaterialsCeramic MembranesDendrimersGold NanoparticlesIron Oxide NanoparticlesMaterials by ApplicationMesoporous MaterialsMetals and Metal AlloysNano Minerals: NanoclaysOLED Materials >>Dopant
HostHTMOLED IntermediatesOther OLED related materialsOptical Materials >>Coumarin DyesCyanine and Squarylium DyesDCM DyesDipyrromethene DyesFluorescence MaterialsFluorescent ProbesHeat and Pressure Sensitive DyesNear-Infrared (NIR) DyesOrganic Non-Linear Optical (NLO) MaterialsOrganic Pigments >>Organic PigmentOther Materials >>Material OtherPolymer Science >>MonomersPolymer AdditivesPolymerization ReagentsPolymersResins
Contact Us
Home Cart 0 Sign in  
Chemistry
Heterocyclic Building Blocks
Piperidines
2-(piperidin-1-yl)ethan-1-amine
1-(2-Aminoethyl)piperidine
Chemistry
Heterocyclic Building Blocks
Organic Building Blocks
Piperidines
Amines Aliphatic Heterocycles
2-(piperidin-1-yl)ethan-1-amine
aminoethyl

[ CAS No. 27578-60-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 27578-60-5
Chemical Structure| 27578-60-5
Structure of 27578-60-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

For Research Only 120K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 27578-60-5 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 27578-60-5 ]

SDS Specification
Alternatived Products of [ 27578-60-5 ]
Product Citations

Product Citations      Expand+

Álvaro Peña ; Juan Heredero ; Beatriz Blandín , et al. DOI:

Abstract: Ionizable lipids are an essential component of lipid nanoparticles (LNPs) for an efficient mRNA delivery. However, optimizing their chemical structures for high protein expression, efficient endosomal escape, and selective organ targeting remains challenging due to complex structure-activity relationships and multistep synthesis. In this study, we introduce a rapid, high-throughput platform for screening ionizable lipids using a two-step, scalable synthesis involving a one-pot 3-component click-like reaction. This method, herein known as the STAAR approach, standing for Sequential Thiolactone Amine Acrylate Reaction, allowed for the combinatorial synthesis and in vivo screening of 91 novel lipids, followed by a structure-activity study. This led to the development of CP-LC-0729, an ionizable lipid that significantly surpasses the benchmark in protein expression while showing no in vivo toxicity. Additionally, the STAAR lipid platform was further validated by incorporating a one-step strategy to yield a permanently cationic lipid which was tested following a fifth-lipid formulation strategy. The in vivo results showed a highly selective lung delivery with a 32-fold increase in protein expression, outperforming current endogenous targeting strategies. All these findings underscore the potential of lipid CP-LC-0729 and the STAAR lipid platform in advancing the efficiency and specificity of mRNA delivery systems, while also advancing the development of new ionizable lipids.

Keywords: lipid nanoparticle ; ionizable lipid ; drug delivery ; lipids ; extrahepatic ; lung targeting ; mRNA therapeutics

Purchased from AmBeed: ;

Li, Bowen ; Manan, Rajith Singh ; Liang, Shun-Qing , et al. DOI: PubMed ID:

Abstract: The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for mRNA and CRISPR-Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Product Details of [ 27578-60-5 ]

CAS No. :27578-60-5 MDL No. :MFCD00006516
Formula : C7H16N2 Boiling Point : No data available
Linear Structure Formula :NH2C2H4NC5H10 InChI Key :CJNRGSHEMCMUOE-UHFFFAOYSA-N
M.W : 128.22 Pubchem ID :33944
Synonyms :
Chemical Name :N-(2-Aminoethyl)piperidine

Calculated chemistry of [ 27578-60-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.17
TPSA : 29.26 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.77 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.97
Log Po/w (XLOGP3) : 0.44
Log Po/w (WLOGP) : 0.05
Log Po/w (MLOGP) : 0.57
Log Po/w (SILICOS-IT) : 0.83
Consensus Log Po/w : 0.77

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.78
Solubility : 21.3 mg/ml ; 0.166 mol/l
Class : Very soluble
Log S (Ali) : -0.62
Solubility : 30.6 mg/ml ; 0.239 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.01
Solubility : 12.4 mg/ml ; 0.0966 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.01

Safety of [ 27578-60-5 ]

Signal Word:Danger Class:8,3
Precautionary Statements:P280-P305+P351+P338-P310 UN#:2734
Hazard Statements:H226-H314 Packing Group:Ⅱ
GHS Pictogram:

Application In Synthesis of [ 27578-60-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 27578-60-5 ]

[ 27578-60-5 ] Synthesis Path-Downstream   1~8

  • 1
  • [ 110-89-4 ]
  • [ 926-39-6 ]
  • [ 27578-60-5 ]
Reference： [1]Patent: DE744996,1940,
    DRP/DRBP Org.Chem.,
  • 2
  • [ 27578-60-5 ]
  • [ 42926-52-3 ]
  • 2-ethoxy-benzoic acid-(2-piperidino-ethylamide) [ No CAS ]
Reference： [1],1957,vol. 4,p. 153,154
    Chem.Abstr.,1958,p. 7207
  • 3
  • [ 27578-60-5 ]
  • [ 33045-53-3 ]
  • [ 102535-21-7 ]
Reference： [1]Journal of Medicinal Chemistry,1986,vol. 29,p. 1814 - 1820
  • 4
  • [ 27578-60-5 ]
  • [ 6492-86-0 ]
  • 6-Amino-2-(2-piperidin-1-yl-ethyl)-benzo[de]isoquinoline-1,3-dione [ No CAS ]
Reference： [1]Journal of Physical Chemistry A,1997,vol. 101,p. 3461 - 3466
  • 5
  • [ 27578-60-5 ]
  • [ 27018-76-4 ]
  • 1-benzyl-1<i>H</i>-indole-3-carboxylic acid (2-piperidin-1-yl-ethyl)-amide [ No CAS ]
Reference： [1]European Journal of Medicinal Chemistry,1999,vol. 34,p. 93 - 105
  • 6
  • [ 27578-60-5 ]
  • [ 58656-98-7 ]
  • [ 733785-78-9 ]
YieldReaction ConditionsOperation in experiment
64% at 120℃; Step 1: tert-Butyl 4- (2- (piperidin-1-yl) ethylamino) benzoate (187) [0348] tert-Butyl 4-FLUOROBENZOATE 185 (0.502g, 2.55 MMOL) and 24PIPERIDIN-1-YL) ETHANAMINE 186 (1.46 mL, 10.21 MMOL) were stirred neat at 120C overnight then diluted with ethyl acetate, washed with saturated aqueous sodium bicarbonate (LX), brine (LX), dried over magnesium sulfate and evaporated to give 187 (0.501g, 64%). H NMR: (DMSO) 6 (ppm): 400 MHz, (DMSO) d (ppm): 7.59 (d, J= 8.8 Hz, 2H), 6.55 (d, J= 8.8 Hz, 2H), 6.24 (t, J= 5.1 Hz, 1H), 4.11 (m, 2H), 3.21 to 3.13 (m, 6H), 2.44 (t, J= 7.1 Hz, 2H), 2.37 (m, 2H), 1.49 (s, 9H), 1.47 to 1.38 (m, 2H). MS: 304.22 (CALC), 249.1 (M-T8U).
Reference： [1]Patent: WO2005/30704,2005,A1 .Location in patent: Page/Page column 206
  • 7
  • [ 27578-60-5 ]
  • [ 171243-30-4 ]
  • [ 1415400-66-6 ]
YieldReaction ConditionsOperation in experiment
65% In dichloromethane; at 20℃; for 0.5h; General procedure: To a solution of benzoyl chloride (1 mmol) in dry dichloromethane (10 ml) was added amine (1 mmol), and the mixture was stirred for 0.5 h at room temperature. After solvent evaporation, the crude product was purified by column chromatography on silica (CHCl3:CH3CH2OH = 9:1) resulting in yellow thick oil and crystallized from the dichloromethane-petroleum ether mixture.
Reference： [1]European Journal of Medicinal Chemistry,2012,vol. 57,p. 211 - 216
  • 8
  • [ 27578-60-5 ]
  • [ 23351-91-9 ]
  • 5-bromo-N1,N3-bis[2-(piperidin-1-yl)ethyl]benzene-1,3-dicarboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
89% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; at 20℃; for 16h; To a solution of <strong>[23351-91-9]5-bromoisophthalic acid</strong> 1(200 mg, 0.82 mmol) and 1-piperidineethanamine (240 mL, 1.17mmol) in DMF (2.5 mL) was added EDC*HCl (330 mg, 1.73 mmol) and HOBt-H2O (25.2 mg, 0.165 mmol). The reaction mixture was stirred for 16 h at room temperature. 10 mL of saturated NaHCO3 solution was added. The aqueous layer was extracted with DCM(3 10 mL). The combined organic layer was dried over MgSO4 and evaporated. The residue was purified by flash chromatography(DCM/MeOH(NH3), 10:0 to 9.7:0.3 (v/v)). The title compound 14(340 mg, 0.73 mmol, 89percent) was obtained as a white solid. Mp:127.3 C. 1H NMR (300 MHz), d (ppm, CDCl3): 8.23 (t, J = 1.5 Hz,1H); 8.04 (d, J = 1.5 Hz, 2H); 7.46 (t, J = 4.7 Hz, 2H); 3.48 (td, J =5.9 Hz, J = 5.5 Hz, 4H); 2.50 (t, J = 6.1 Hz, 4H); 2.38 (m, 8H); 1.54(m, 8H); 1.40 (m, 4H). 13C NMR (75 MHz), d (ppm, CDCl3): 165.3;136.3; 133.2; 123.7; 123.0; 57.4; 54.3; 36.6; 25.7; 24.2. LC?MS(ESI) m/z Calculated: 465.2?467.2, Found: 465.0?466.9, 233.1?234.0 [(M+2H)/2]+.
Reference： [1]Bioorganic and Medicinal Chemistry,2018,vol. 26,p. 2151 - 2164

Tags: 27578-60-5 synthesis path| 27578-60-5 SDS| 27578-60-5 COA| 27578-60-5 purity| 27578-60-5 application| 27578-60-5 NMR| 27578-60-5 COA| 27578-60-5 structure

Recommend Products
Same Skeleton Products
Related Products
Isomers
Categories
Chemistry
Heterocyclic Building Blocks
Piperidines
Chemistry
Organic Building Blocks
Amines
Chemistry
Organic Building Blocks
Amines
aminoethyl
Chemistry
Heterocyclic Building Blocks
Aliphatic Heterocycles

Technical Information

• Buchwald-Hartwig C-N Bond and C-O Bond Formation Reactions • Chan-Lam Coupling Reaction • Hydride Reductions • Leuckart-Wallach Reaction • Mannich Reaction • Petasis Reaction • Preparation of Amines • Reactions of Amines • Specialized Acylation Reagents-Vilsmeier Reagent • Ugi Reaction
Historical Records

Related Functional Groups of
[ 27578-60-5 ]

Amines

Chemical Structure| 100911-49-7

[ 100911-49-7 ]

2-(Piperidin-1-yl)ethanamine dihydrochloride

Similarity: 0.95

Chemical Structure| 1001353-92-9

[ 1001353-92-9 ]

(R)-1-Methylpiperidin-3-amine

Similarity: 0.86

Chemical Structure| 902152-76-5

[ 902152-76-5 ]

(S)-1-Methylpiperidin-3-amine

Similarity: 0.86

Chemical Structure| 7154-73-6

[ 7154-73-6 ]

Pyrrolidinoethylamine

Similarity: 0.85

Chemical Structure| 1116-76-3

[ 1116-76-3 ]

Trioctylamine

Similarity: 0.84

Related Parent Nucleus of
[ 27578-60-5 ]

Piperidines

Chemical Structure| 100911-49-7

[ 100911-49-7 ]

2-(Piperidin-1-yl)ethanamine dihydrochloride

Similarity: 0.95

Chemical Structure| 1001353-92-9

[ 1001353-92-9 ]

(R)-1-Methylpiperidin-3-amine

Similarity: 0.86

Chemical Structure| 902152-76-5

[ 902152-76-5 ]

(S)-1-Methylpiperidin-3-amine

Similarity: 0.86

Chemical Structure| 1157849-51-8

[ 1157849-51-8 ]

(S)-1-Methylpiperidin-3-amine dihydrochloride

Similarity: 0.83

Chemical Structure| 14759-09-2

[ 14759-09-2 ]

1-(2-(Piperidin-4-yl)ethyl)piperidine

Similarity: 0.81

; ;